Skip to content
REGION
Linkedin page opens in new windowX page opens in new window
Login
Vesalio
Vesalio Acute Ischemic Stroke
VesalioVesalio
  • Home
  • Technology
    • Discover NeVa
    • Discover NeVa Net
    • Discover NeVa VS
    • Discover enVast
    • Discover pVasc
  • Clinical
    • NeVa Publications
    • NeVa Clinical Cases
    • NeVa VS Clinical Cases
    • NEVA VS VITAL STUDY
    • NEVA VS SNIS 2024
    • enVast Publications
    • enVast Clinical Cases
  • Team
    • Leadership Team
    • Board of Directors
  • About
    • Vision & History
    • Careers
  • News
    • Blog Articles
    • Press Releases
  • Resources
    • NeVa Resources
    • enVast Resources
  • Contact
  • Home
  • Technology
    • Discover NeVa
    • Discover NeVa Net
    • Discover NeVa VS
    • Discover enVast
    • Discover pVasc
  • Clinical
    • NeVa Publications
    • NeVa Clinical Cases
    • NeVa VS Clinical Cases
    • NEVA VS VITAL STUDY
    • NEVA VS SNIS 2024
    • enVast Publications
    • enVast Clinical Cases
  • Team
    • Leadership Team
    • Board of Directors
  • About
    • Vision & History
    • Careers
  • News
    • Blog Articles
    • Press Releases
  • Resources
    • NeVa Resources
    • enVast Resources
  • Contact

Category Archives: Press Releases

You are here:
  1. Home
  2. Category "Press Releases"

Vesalio Announces Launch of pVasc Study in the U.S. While Featuring the pVasc Thrombectomy System at VIVA, VEITH, and TCT

Press ReleasesBy vesalioOctober 25, 2024

Vesalio Introduces pVasc™ U.S. Clinical Study to capture real-world data and optimize results for patients suffering from peripheral vascular disease.

Vesalio launches pVasc Thrombectomy System in the U.S. for peripheral occlusions

Press ReleasesBy Tiffany FuentesSeptember 4, 2024

Introducing pVasc™ mechanical thrombectomy system for the safe and effective non-surgical removal of occlusions from the peripheral vasculature

VESALIO Introduces NeVa NET 4.0 mm Following International Success of NeVa NET 5.5 mm

Press ReleasesBy Tiffany FuentesJuly 10, 2024

Vesalio hires Bob Bushok as VP of U.S. Sales and announces high first-pass rates and favorable safety profile in a 145-stroke patient data set for the NeVa™ thrombectomy device with findings published in the journal Interventional Neuroradiology.

Vesalio appoints CFO and announces company headquarters in Dallas, Texas

Press ReleasesBy Tiffany FuentesMay 21, 2024

Introducing pVasc™ mechanical thrombectomy system for the safe and effective non-surgical removal of occlusions from the peripheral vasculature

NeVa CLEAR Study results presented at ESMINT: innovative thrombectomy device achieves notable first-pass success and patient outcomes

Press ReleasesBy vesalioSeptember 21, 2023

Primary results from the CLEAR Study were presented at the ESMINT annual meeting in Marseille, France (4-6 September 2023), where Vesalio also announced the fifth anniversary of the international commercialization of the NeVa™ device.

Vesalio Announces Initial Use of its Uniquely Designed and FDA-approved NeVa VS Device

Press ReleasesBy Tiffany FuentesFebruary 23, 2023

Vesalio Introduces pVasc™ U.S. Clinical Study to capture real-world data and optimize results for patients suffering from peripheral vascular disease.

Vesalio appoints VP of U.S. Sales and announces recent publication on NeVa showing impressive first pass rates

Press ReleasesBy vesalioNovember 29, 2022

Vesalio hires Bob Bushok as VP of U.S. Sales and announces high first-pass rates and favorable safety profile in a 145-stroke patient data set for the NeVa™ thrombectomy device with findings published in the journal Interventional Neuroradiology.

Vesalio announces EU MDR Certification

Press ReleasesBy vesalioOctober 13, 2022

MDR certification confirms the company’s commitment of ensuring that their innovative new products meet or exceed these rigorous new standards.

Vesalio announces FDA Approval of the NeVa VS™

Press ReleasesBy vesalioSeptember 15, 2022

NeVa VS is a patented retrievable nitinol stent specifically designed to treat cerebral vasospasm after aneurysmal rupture.

Vesalio announces CE Approval for new NeVa NET™

Press ReleasesBy vesalioSeptember 1, 2022

The first integrated clot micro-filtration technology for stroke thrombectomy patients.

→123→
vesalio_logo_white2
LEARN
  • About
  • Technology
  • Clinical
EXPLORE
  • News
  • Leadership
  • Careers
CONNECT

 
This field is for validation purposes and should be left unchanged.

icon_mail

info@vesalio.com

© 2025 Vesalio Inc. All rights reserved

Privacy Policy    Terms Of Use
Go to Top
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Accept AllCookie Settings
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT

CHANGING OUTCOMES

CHANGING LIVES

by removing vascular occlusions and restoring blood flow

Please select your region to enter our world of innovation:

"*" indicates required fields

Consent*
This field is for validation purposes and should be left unchanged.

Name(Required)
Drop files here or
Max. file size: 50 MB, Max. files: 3.
    This field is for validation purposes and should be left unchanged.